• For Patients: Clinical Trials
  • Publications
  • Careers
  • Contact Us
INOVIO Pharmaceuticals
  • About Inovio
    • Mission and Values
    • Inovio Firsts
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • CEO Corner
    • Partnerships
  • DNA Medicines Technology
    • Optimized Plasmid Design and Delivery
    • DNA Medicines Explained
    • Technology Advantages
    • Pioneering dMAb™ Science
  • Our Focus: Serving Patients
    • Empowering Human Immunity
    • HPV-Associated Diseases
    • Immuno-Oncology
    • Infectious Diseases
    • Covid-19
  • DNA Medicines Pipeline
  • Investors & Media
    • Events & Presentations
    • Stock Information
    • News Releases
    • SEC Filings
    • Analyst Coverage
    • Corporate Governance
    • Shareholder Services
    • FAQ
  • For Patients: Clinical Trials
  • Publications
  • Careers
  • Contact Us
INOVIO Pharmaceuticals
  • About Inovio
  • DNA Medicines Technology
    • Optimized Plasmid Design and Delivery
    • DNA Medicines Explained
    • Technology Advantages
    • Pioneering dMAb™ Science
  • Our Focus: Serving Patients
    • Empowering Human Immunity
    • HPV-Associated Diseases
    • Immuno-Oncology
    • Infectious Diseases
    • Covid-19
  • DNA Medicines Pipeline
  • Investors & Media
    • Events & Presentations
    • Stock Information
    • News Releases
    • SEC Filings
    • Analyst Coverage
    • Corporate Governance
    • Shareholder Services
    • FAQ
  • For Patients: Clinical Trials
  • Publications
  • Careers
  • Contact Us
  • Mission and Values
  • Inovio Firsts
  • Leadership
  • Board of Directors
  • Scientific Advisory Board
  • CEO Corner
  • Partnerships

CEO CORNER

Dr. J. Joseph Kim

J. Joseph Kim, Ph.D.
President, Chief Executive Officer, Director

CEO CORNER

Dr. J. Joseph Kim

J. Joseph Kim, Ph.D.
President, Chief Executive Officer, Director
April 14, 2020

Harnessing the Power of DNA Medicines

While the rising threat of the COVID-19 coronavirus has captured the world’s attention and is a focus at INOVIO as we race to bring our COVID-19 DNA vaccine to human clinical trials in April, we are reminded by International HPV Awareness Day of the critical need to combat the human papillomavirus, which impacts 80% of […]

Read More

January 21, 2020

Can One Question Change an Organization’s Culture?

Today we observe the birthday of a leader who stood for equality, respect, and diversity – Martin Luther King, Jr.  This man, who followed a dream that changed laws and attitudes, spoke words we still remember more than 50 years after his death.  His words that I hold dear are: “I have a dream that my four […]

Read More

SUBSCRIBE FOR UPDATES FROM INOVIO
Register to receive email alerts for INOVIO press releases

INOVIO Pharmaceuticals
  • About Inovio
  • DNA Medicines Technology
  • Our Focus: Serving Patients
  • DNA Medicines Pipeline
  • Investors & Media
  • For Patients
  • Publications
  • Careers
  • Contact Us
  • Safe Harbor Statement
  • Expanded Access
  • Privacy Policy
  • Terms & Conditions

© Copyright 2021 INOVIO Pharmaceuticals. All rights reserved.